Logos Global Management »

Silence Therapeutics shares owned by Logos Global Management

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Logos Global Management from 13F filings

Historical chart of Logos Global Management investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Logos Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Logos Global Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9M 400k 17.37

More positions owned by Logos Global Management

Cytokinetics Com New (CYTK)
Apellis Pharmaceuticals (APLS)
Sarepta Therapeutics Call Option (SRPT)
Ideaya Biosciences (IDYA)
Argenx Se Sponsored Adr (ARGX)
Olema Pharmaceuticals (OLMA)
Immunovant (IMVT)
Structure Therapeutics Sponsored Ads (GPCR)
Rocket Pharmaceuticals (RCKT)
Rayzebio
Ambrx Biopharma
Karuna Therapeutics Ord
Immunocore Hldgs Ads (IMCR)
Dyne Therapeutics (DYN)
Morphosys Sponsored Ads Call Option (MOR)

View all positions for Logos Global Management

Top funds holding Silence Therapeutics

Artal Group
BVF
Vivo Capital
Aquilo Capital Management
Frazier Life Sciences Management
Logos Global Management
M28 Capital Management
Lynx1 Capital Management
Hsbc Holdings
Cantor Fitzgerald, L. P.
UBS Group
Citigroup
Schonfeld Strategic Advisors
William Blair $ Company
Citadel Advisors

View all funds holding Silence Therapeutics